The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

On August 22, Moderna announced that FDA approved ... On the same day, Pfizer and BioNTech also announced that they received approval for their sBLA for an updated composition of their Omicron ...

When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

Its cost savings would include a cut of $1.1 billion from research and development from 2026, with most of the actions in ...

AND FOR THOSE THAT ARE OLDER PATIENTS, OVER 60 AND AND HAVE COMORBIDITIES, THE RSV VACCINE ... old receive both an updated ...

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans ...

The Hawaii Department of Health is recommending residents get updated flu and COVID-19 vaccines that are now available.

Moderna pushed its break-even goal by two years as it delayed the timeline for developing several key products and predicted ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, ...